The global next generation sequencing market size was estimated at USD 9.78 billion in 2019 and is projected to grow at a CAGR 11.7% during the forecast period. With the reducing cost of sequencing, Next Generation Sequencing (NGS) is anticipated to witness diversification into a substantial number of clinical areas.